Stay updated on VS-6766 and Everolimus Clinical Trial
Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.

Latest updates to the VS-6766 and Everolimus Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision history updated: added 'Revision: v3.4.3' and removed 'Revision: v3.4.2'.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.4.2 was added, and the earlier government funding/operating-status notices (v3.4.1) were removed.SummaryDifference0.4%

- Check60 days agoChange DetectedA government funding notice was added at the top of the page stating potential delays and that the NIH Clinical Center is open. The recruitment status indicator 'Active, not recruiting' was removed, and the page includes a revision notice (Revision: v3.4.1) with updated dates in January 2026.SummaryDifference0.9%

- Check67 days agoChange DetectedThe page adds a 'Show glossary' option and introduces QC-related labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new Revision: v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.2%

- Check81 days agoChange Detected- Revision label updated from v3.3.3 to v3.3.4. No user-facing content changes were detected.SummaryDifference0.0%

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.